Chemical Compound

Cytidine, 2',3'-dideoxy-; 2',3'-Dideoxycytidine; D 2C; Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000; Zalcitabine; ddC

CAS Registry Number 7481-89-2
Cytidine, 2',3'-dideoxy-; 2',3'-Dideoxycytidine; D 2C; Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000; Zalcitabine; ddC 结构式
Primary record

Cytidine, 2',3'-dideoxy-; 2',3'-Dideoxycytidine; D 2C; Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000; Zalcitabine; ddC

库存
3,607 克
纯度
98.7 %
CAS
7481-89-2

化合物标识与属性

CAS
7481-89-2
PubChem CID
24066
SMILES
C1C[C@@H](O[C@@H]1CO)N2C=CC(=NC2=O)N
Canonical SMILES
Nc1ccn([C@H]2CC[C@@H](CO)O2)c(=O)n1

名称与同义词

  • zalcitabine
  • Dideoxycytidine
  • 2',3'-DIDEOXYCYTIDINE
  • ddCyd
  • HIVID
  • 7481-89-2
  • Zalcitibine
  • zalcitabina
  • ddC (Antiviral)
  • Cytidine, 2',3'-dideoxy-
  • zalcitabinum
  • Zalcitabine?
  • 2,3-dideoxycytidine
  • HIVID Roche
  • Hivid(TM)
  • Zalcitabine(DDC)
  • Hivid (TN)
  • Beta-D-DDC
  • DdC & IFN-alpha
  • C9H13N3O3
  • ddC & sCD4
  • 2',3' Dideoxycytidine
  • ddC & GM-CSF
  • PC-SOD & ddC
  • ddC & IFN.alpha.
  • .beta.-D-DDC
  • dideoxycytidine (DDC)
  • Interferon AD + ddC
  • 2', 3'-dideoxycytidine
  • 6L3XT8CB3I
  • Zalcitabine (Standard)
  • CCRIS 692
  • CHEMBL853
  • DdC & Interferon alpha
  • DDC (DDC)
  • UNII-6L3XT8CB3I
  • DTXSID0023747
  • ZALCITABINE [MI]
  • Prestwick0_001037
  • Prestwick1_001037
  • Prestwick2_001037
  • Prestwick3_001037
  • RefChem:389367
  • Zalcitabine [USAN:INN:BAN]
  • ddC & Interferon.alpha.
  • ZALCITABINE [INN]
  • ZALCITABINE [JAN]
  • NSC 606170
  • WREGKURFCTUGRC-POYBYMJQSA-N
  • MFCD00012188
  • ZALCITABINE [HSDB]
  • ZALCITABINE [IARC]
  • ZALCITABINE [USAN]
  • bmse000712
  • D0DC7N
  • D0M1YO
  • D0Z9QR
  • UPCMLD-DP115
  • Zalcitabine (JAN/USP/INN)
  • HSDB 7156
  • ZALCITABINE [VANDF]
  • AC1L2N6R
  • SCHEMBL3598
  • DTXCID703747
  • TimTec1_004969
  • DS-4152 & ddC
  • ZALCITABINE [MART.]
  • 2',3'-Dideoxy-D-cytidine
  • Lopac0_000360
  • BSPBio_001253
  • Ro 24-2027/000
  • Ro-24-2027/000
  • ZALCITABINE [USP-RS]
  • ZALCITABINE [WHO-DD]
  • CHEBI:10101
  • ddC
  • MLS000069636
  • MLS000759540
  • MLS001055363
  • MLS001424210
  • MLS006011951
  • NSC-606170
  • Zalcitabine (dideoxycytidine,ddc)
  • SPBio_003104
  • NSC606170
  • Zalcitabine [USAN:BAN:INN]
  • 2 ,3 -Dideoxycytidine
  • BPBio1_001378
  • GTPL4828
  • orb1310928
  • 2',3'-ddC
  • ddC & NP (from PHCA or HSA)
  • ddC|||2',3'-Dideoxycytidine
  • 4-Amino-1-((2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
  • SCHEMBL10378805
  • SRI-7707
  • UPCMLD-DP115:001
  • Zalcitabine - Bio-X trade mark
  • Zalcitabine [USAN:USP:INN:BAN]
  • KS-00000MRJ
  • ZINC39906
  • AOB5609
  • BRN 0654956
  • J05AF03
  • ZALCITABINE [ORANGE BOOK]
  • GLXC-06578
  • HMS1548B19
  • HMS1571O15
  • HMS2051H18
  • HMS2090C12
  • HMS2098O15
  • HMS2236N08
  • HMS3261G21
  • HMS3715O15
  • Pharmakon1600-01502360
  • ZALCITABINE [USP IMPURITY]
  • .beta.-D-2',3'-Dideoxycytidine
  • Zalcitabine, 2'3'-Dideoxycytidine
  • BCP13878
  • CID24066
  • KS-1130
  • Hivid;Dideoxycytidine;NSC 606170
  • Ro-242027000
  • Tox21_113491
  • Tox21_201655
  • Tox21_303169
  • Tox21_500360
  • AC-824
  • ANW-36530
  • BDBM50145605
  • C9-H13-N3-O3
  • CID:24066
  • EBC-07537
  • HY-17392R
  • NCGC00090705-08
  • NSC759655
  • Ro-24-2027000
  • s1719
  • SBB066036
  • AKOS015854844
  • AKOS015894505
  • Tox21_113491_1
  • 1-(2,3-Dideoxy-beta-D-ribofuranosyl)cytosine
  • BETA-D-2',3'-DIDEOXYCYTIDINE
  • CCG-101050
  • CS-1110
  • DB00943
  • LP00360
  • LS-1645
  • NC00300
  • ND06559
  • NSC-759655
  • RTC-064018
  • SDCCGSBI-0050348.P002
  • SRI-7707-13
  • SRI-7707-14
  • SRI-7707_15
  • SRI-7707_17
  • NCGC00090705-01
  • NCGC00090705-02
  • NCGC00090705-03
  • NCGC00090705-05
  • NCGC00090705-06
  • NCGC00090705-07
  • NCGC00090705-09
  • NCGC00090705-10
  • NCGC00090705-11
  • NCGC00090705-13
  • NCGC00090705-15
  • NCGC00090705-24
  • NCGC00090705-25
  • NCGC00179242-01
  • NCGC00257202-01
  • NCGC00259204-01
  • NCGC00261045-01
  • AJ-08916
  • AN-15472
  • BC203863
  • BD164564
  • BP-58631
  • CPD000058253
  • HY-17392
  • K278
  • SAM001246779
  • SC-09165
  • SID:53788261
  • SMR000058253
  • ST069364
  • SY106119
  • ZB001188
  • 2',3'-Dideoxycytidine & Interferon-alpha
  • 2',3'-Dideoxycytidine;ddC;Dideoxycytidine
  • CAS-7481-89-2
  • D 5782
  • ddC;Dideoxycytidine;2',3'-Dideoxycytidine
  • 2',3'-Dideoxycytidine & Interferon.alpha.
  • 2',3'-Dideoxycytidine, >=98% (HPLC)
  • AB0014137
  • AB2000246
  • DB-019728
  • J277.119E
  • TC-064018
  • B2223
  • D3581
  • EU-0100360
  • NS00005543
  • ST24043185
  • SW197364-4
  • 5-25-14-00313 (Beilstein Handbook Reference)
  • Cytidine, 2',3'-dideoxy & Interferon alpha
  • Ro-24-2027-000
  • C07207
  • C76390
  • D00412
  • EN300-120633
  • M-2084
  • 2',3'-DIDEOXYCYTIDINE-5'-MONOPHOSPHATE
  • 4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
  • 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2(1H)-one
  • 42060-EP2295503A1
  • 42060-EP2298761A1
  • 42060-EP2305695A2
  • 42060-EP2305696A2
  • 42060-EP2305697A2
  • 42060-EP2305698A2
  • 42060-EP2311808A1
  • 42060-EP2311829A1
  • 78798-EP2298783A1
  • 78798-EP2305695A2
  • 78798-EP2305696A2
  • 78798-EP2305697A2
  • 78798-EP2305698A2
  • Cytidine, 2',3'-dideoxy- & Interferon.alpha.
  • 481D892
  • A838234
  • D016047
  • F222318
  • Hivid, Dideoxycytidine, NSC 606170, Zalcitabine
  • SR-01000075822
  • SR-01000736919
  • ZALCITABINE (DIDEOXYCYTIDINE,DDC) [VANDF]
  • 2',3'-Dideoxycytidine & sCD4(soluble recombinant protein)
  • 3'-Azido-3'-deoxythymidine/2',3'-Dideoxycytidine
  • Q2344582
  • SR-01000075822-1
  • SR-01000736919-5
  • 4-AMINO-1-[(2R,5S)-5-(HYDROXYMETHYL)OXOLAN-2-YL]-1,2-DIHYDROPYRIMIDIN-2-ONE
  • BRD-K85925969-001-16-6
  • BRD-K85925969-001-17-4
  • Cytidine, 2',3'-dideoxy- & Colony-stimulating factor
  • Cytidine, 2',3'-dideoxy-& Colony-stimulating factor
  • 4-amino-1-[(2R,5S)-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidin-2-one
  • Ro-242027000/Ro-24-2027-000
  • Z1550648753
  • 4-amino-1-[5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
  • Lecithinized superoxide dismutase & .beta.-D-2',3'-Dideoxycytidine
  • Sulfated polysaccharide-peptidoglycan DS-4152 & 2',3'-Dideoxycytidine
  • 1-(dichloromethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole
  • 2',3'-Dideoxycytidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate)
  • 4-amino-1-((2R,5S)-5-(hydroxymethyl)oxolan-2-yl)pyrimidin-2-one
  • 4-Amino-1-(2,3-dideoxy-beta-D-ribofuranosyl)pyrimidine-2(1H)-one
  • Zalcitabine, United States Pharmacopeia (USP) Reference Standard
  • 2 inverted exclamation mark ,3 inverted exclamation mark -Dideoxycytidine
  • 2 inverted exclamation marka,3 inverted exclamation marka-Dideoxycytidine
  • 3-[(5S,2R)-5-(hydroxymethyl)oxolan-2-yl]-6-amino-3-hydropyrimidin-2-one
  • 4-Amino-1-(5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidin-2-one
  • 4-Amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2(1H)-one
  • .beta.-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor
  • 4-amino-1-((2R,5S)-5-(hydroxymethyl)oxolan-2-yl)-1,2-dihydropyrimidin-2-one
  • Beta-D-2',3'-Dideoxycytidine & Granulocyte-macrophage colony-stimulating factor
  • 107-95-9
  • 620-762-3
  • 748110-64-7
  • Cytidine, 2',3'-dideoxy-; 2',3'-Dideoxycytidine; D 2C; Dideoxycytidine; Hivid; NSC 606170; Ro 24-2027/000; Zalcitabine; ddC
  • D2C
  • DOC